İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2002 · article

Serum homocysteine level is increased and correlated with endothelin 1 and nitric oxide in Behcet s disease

ISSN0007-1161
YÖKSİS OpenAlex Açık erişim · bronze Üst %10
Yıl2002
Atıf91OpenAlex
Atıf99Semantic Scholar · 7 etkili
Yüzdelik%97,0
FWCI6,911,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q2

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıBritish Journal of Ophthalmology
  • Katalog eşleşmesi (ISSN)British Journal of Ophthalmology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

BACKGROUND/AIMS: Behçet's disease (BD) is a systemic inflammatory vasculitis of young adults with unknown aetiology, characterised by endothelial dysfunction and occlusion in both deep venous and retinal circulation. Ocular involvement occurs in 70% of cases and is characterised by periphlebitis, periarteritis, vascular occlusion, and thrombosis leading to blindness despite vigorous treatment. Endothelin-1 (ET-1) is a vasoconstricting peptide while nitric oxide (NO) is a relaxing molecule and both are released by endothelium for blood flow regulation. Homocysteinaemia is a newly defined term connected to the increased risk of atherothrombotic and atherosclerotic systemic and retinal vascular occlusive diseases, and its role in the course of BD has not been previously described. The authors aimed to detect serum total homocysteine (tHcy), ET-1, and NO in BD and to assess if tHcy, ET-1, and NO are associated with ocular BD or disease activity. METHODS: 43 consecutive patients with ocular (n = 27) or non-ocular (n = 16) BD (36.95 (SD 9.80) years, 22 male, 21 female) satisfying international criteria, and 25 age and sex matched healthy control subjects (37.88 (8.73) years, 13 male, 12 female) without a history of systemic or retinal venous thrombosis were included in this study. Patients were examined by two ophthalmologists with an interest in BD. Serum tHcy, ET-1, and NO concentrations were measured in both groups. Hyperhomocysteinaemia was defined as a tHcy level above the 95th percentile in the control group. Patients were divided into active and inactive period by acute phase reactants including alpha(1) antitrypsin, alpha(2) macroglobulin, erythrocyte sedimentation rate, and neutrophil count. RESULTS: The overall mean serum tHcy, ET-1, and NO levels were significantly higher in patients with BD than in control subjects (tHcy = 15.83 (4.44) v 7.96 (2.66) ng/ml, p <0.001; ET-1 = 17.47 (4.33) v 5.74 (2.34) micromol/ml, p <0.001; NO = 37.60 (10.31) v 27.08 (7.76) micromol/l, p <0.001). Serum tHcy, ET-1, and NO levels were significantly higher in active patients than in inactive patients and control subjects. In addition, among patients with ocular BD, the mean tHcy levels were significantly increased and correlated with ET-1 and NO levels when compared with non-ocular disease and control subjects. All acute phase reactant levels were significantly higher in active period than in inactive stage and controls. CONCLUSIONS: Elevated tHcy may be responsible for the endothelial damage in BD and may be an additional risk factor for the development of retinal vascular occlusive disease, contributing to the poor visual outcome in these patients. Assessment of tHcy may be important in the investigation and management of patients with BD, especially with ocular disease.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

91atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 38 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2002 Serum levels of TNF sIL 2R IL 6 and IL 8 are increased and associated with elevated lipid peroxidation in patients with Behçet s diseaseAtıf 236 · OpenAlex
  2. 2003 Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet s syndromeAtıf 97 · OpenAlex
  3. 2003 Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet s syndromeAtıf 97 · OpenAlex
  4. 2003 Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet s syndromeAtıf 97 · OpenAlex
  5. 2003 Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behcet’xxs disease: original contributions/clinical and laboratory investigationsAtıf 63 · OpenAlex
  6. 2012 Pathophysiology of the Behçet s DiseaseAtıf 59 · OpenAlex
  7. 2004 Vascular endothelial function and plasma homocysteine levels in Behcet s diseaseAtıf 56 · OpenAlex
  8. 2004 Vascular endothelial function and plasma homocysteine levels in Behcet s diseaseAtıf 56 · OpenAlex
  9. 2004 Vascular endothelial function and plasma homocysteine levels in Behcet s diseaseAtıf 56 · OpenAlex
  10. 2004 Vascular endothelial function and plasma homocysteine levels in Behcet s diseaseAtıf 56 · OpenAlex

Yazarlar

7
  1. Hamdi Er 1
  2. Cem Evereklioğlu 2
  3. TONGABAY CUMURCU 3
  4. YUSUF TÜRKÖZ 4
  5. ELİF GÜREL 5
  6. KAZIM ŞAHİN RECEP TAYYİP ERDOĞAN ÜNİVERSİTESİ 6
  7. Selim Doğanay 7